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ABSTRACT The binding of Eu3` with Ca2+-stimulated, Mg2+-dependent adenosine triphosphatase ([Ca2` + Mg2+]-
ATPase) of cardiac sarcoplasmic reticulum (SR) has been investigated using direct laser excited Eu3+ luminescence.
Eu3+ is found to inhibit both Ca2+-dependent ATPase activity and Ca2+-uptake in a parallel manner. This is attributed
to the binding of Eu3+ to the high affinity Ca2+-binding sites. The Ki for Ca2+-dependent ATPase is -50 nM. The 7Fo0
5Do excitation spectrum of Eu3+ in cardiac SR shows a peak at 579.3 nm, as compared to 578.8 nm in
potassium-morpholino propane sulfonic acid (K-MOPS) pH 6.8. Upon binding with cardiac SR, Eu3+ shows an
increase in fluorescence intensity as well as in lifetime values. The fluorescence decay of bound Eu3+ exhibits a
double-exponential curve. The apparent number of water molecules in the first coordination sphere of Eu3+ in SR is 2.8
for the short component and 1.0 for the long component. In the presence of ATP, a further increase in fluorescence
lifetimes is observed, and the number of water molecules in the first coordination sphere of Eu3` is reduced further to 1.3
and 0.5. The double exponential nature of the decay curve and the different number of water molecules coordinated to
Eu3+ for both decay components suggest that Eu3+ binds to two sites and that these are heterogeneous. The reduction in
the number of H20 ligands in the presence of ATP shows a change in the molecular environment of the Eu3+-binding
sites upon phosphoenzyme formation, with a movement of Eu3+ to an occluded site on the enzyme.
INTRODUCTION
The regulation of intracellular Ca2" levels is the key to the
contraction and relaxation of the cardiac muscle (1). The
sarcoplasmic reticulum (SR) plays a major role in Ca2"
regulation. The ATP-dependent transport of Ca2" across
the SR is mediated by Ca2"-stimulated, Mg2+-dependent
adenosine triphosphatase ([Ca2, + Mg2I]-ATPase), a
single polypeptide of 1 O kD. The active transport of Ca2+
by the cardiac SR has been reported to involve a phospho-
protein intermediate and to proceed by a mechanism
similar to that of skeletal muscle (1-5). However, the rates
of Ca2+ transport and concomitant Ca2+-dependent
hydrolysis of ATP are considerably lower in cardiac SR
than in skeletal SR. A specific protein, phospholamban, is
closely associated with the (Ca2+ ± Mg2+)-ATPase of
cardiac SR. The Ca2+-dependent ATPase activity and the
Ca2+-uptake are activated upon phosphorylation of phos-
pholamban by cAMP-and/or Ca2+-calmodulin-dependent
protein kinase (2-5). Most of the previous studies on the
cardiac SR have focussed mainly on understanding the role
of phospholamban in Ca2+ regulation. However, little is
known about the Ca2+-binding sites. This report deals with
the characterization of the Ca2+-binding sites in the car-
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diac SR and their molecular environment, using Eu3+, as a
first step toward understanding the molecular mechanism
of Ca2" regulation. Lanthanide ions are known as Ca2"
analogue in a variety of biological systems (6). It has been
demonstrated in skeletal SR (Ca2" + Mg2+)-ATPase that
the Ca2+ sites may be effectively probed by Gd3+, Tb3+,
Eu3+, and other lanthanides (7-1 1). The usefulness of the
luminescent lanthanides, such as Eu3+ and Tb3+, has been
greatly extended by the direct laser excitation technique
developed by Horrocks and his group (12-15). The tech-
nique used in the present study involves direct excitation of
the 7Fo-- 5Do transition between the nondegenerate levels
in Eu3+ by means of an intense laser pulse (13). Excitation
profiles and luminescence decay, which are highly sensitive
to the environment of Eu3+, are used to characterize the
distinct Eu3+-binding sites in the system.
MATERIALS AND METHODS
EuCl3 and D20 (99.9%) were purchased from Alfa-Ventron (Danvers,
MA). Tris-ATP was the product of Sigma Chemical Co. (St. Louis,
MO). Adenylyl (,B-y methylene) triphosphate (AMP-PCP) and adenylyl-
imidotriphosphate (AMP-PNP) were obtained from Boehringer Mann-
heim Diagnostics, Inc. (Houston, TX). (,y-32P)ATP and 45CaC12 were
purchased from New England Nuclear, Boston, MA. All other chemicals
were reagent grade.
Cardiac microsomes were prepared from canine heart left ventricle
according to the method of Harigaya and Schwartz (16) with minor
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modifications (17). Cardiac left ventricular muscle was homogenized in
10 mM NaHCO3 and centrifuged at 8,700 g for 20 min. The supernatant
was then centrifuged at 10,000 g for 20 min. The supernatant was
strained through four layers of cheesecloth, followed by centrifugation at
37,000 g for 1 h. The pellet was suspended in 20 mM Tris-maleate, 0.6 M
KCI, pH 6.8, and centrifuged at 100,000 g for 1 h. The pellet containing
microsomes was suspended in 0.25 M sucrose. The protein concentration
was determined from the absorption at 280 nm in 1% SDS using Al% =
10.0 (18) and by the method of Lowry et al. (19).
The ATPase activity was measured by the isotopic method as described
elsewhere (20). Membrane vesicles were suspended at a concentration of
200 ,g protein/ml in 0.4 ml of a reaction mixture containing 100 mM
KCI, 10 mM MgCl2, 5 mM NaN3, 10 mM K-MOPS (pH 6.8), and
CaCl2. CaC12 concentrations were 30 and 60 ,M. EuCl3 concentration
was varied from 0-1 mM. The reaction was initiated by the addition of 5
mM Tris (y-32P)ATP and was carried out at 250C. The reaction was
quenched by adding 0.2 ml of 10% trichloracetic acid (TCA). The
samples were centrifuged, and the free phosphate liberated in the
supernatant was extracted with 8.5% ammonium molybdate and butyl
acetate and counted for radioactivity. The Ca2+-independent ATPase
activity was measured essentially by the above procedure, but 5 mM
EGTA was included instead of CaCl2.
Ca2+-uptake assay was performed by millipore filtration (21). Mem-
brane vesicles were suspended at a concentration of 200 Mg protein/ml in
0.4 ml of reaction mixture, essentially the same as described above for the
ATPase assay except 45CaC12 was included instead of CaCl2. The
concentration of EuCl3 was varied from 0 to 1 mM. The reaction was
started by adding 5 mM Tris-ATP and was carried out at 250C. The
reaction mixture was then filtered through 0.2-,M membranes. The
membrane vesicles bound to the Millipore filter were washed with the
reaction buffer and counted for radioactivity.
Phosphorylation of the SR vesicles was accomplished essentially by the
method of Kirchberger et al. (22) with minor modification (17). Mem-
brane vesicles were suspended at a concentration of 250 MAg protein/ml in
a reaction mixture containing 10mM K-MOPS at pH 6.8, 100 mM KCI,
5 mM MgCl2, 5 mM NaN3, and 20MuM CaCl2, or 20MM EuCI3, or 5 mM
EGTA. The reaction was started by the addition of 50 MM Tris-
('y-32P)ATP and was carried out at 250C. The final volume was 0.2 ml.
The reaction was terminated by adding 2 ml of a cold mixture of 10%
TCA containing 0.1 mM KH2PO4 and 0.2 mM Tris-ATP. 0.2 ml of
0.63% bovine serum albumin (BSA) was added as a carrier protein. The
samples were kept on ice for 15 min, followed by a centrifugation at 2,000
g for 10 min. The pellets were suspended in 0.2 ml of 0.6 N NaOH. The
protein was reprecipitated by the addition of 2 ml of 10% TCA,
centrifuged, resuspended in NaOH and then washed similarly three
times. Finally, the pellet was suspended in 0.2 ml of 0.6 N NaOH and
transferred to scintillation vials for counting radioactivity.
The luminescence instrumentation has been described elsewhere (23).
Briefly, the exciting light for luminescence measurements was provided
by a DL-12 dye laser pumped by a UV-12 pulsed nitrogen laser
(Molectron Corp., Sunnyvale, CA). The line width at 580 nm (Rhoda-
mine 6G dye) is -0.01 nm. The sample housing, the collection optics, and
the associated electronics were built by Photochemical Research Asso-
ciates Inc. (London, Ontario). The emitted photons were selected by a
double monochromator (model DH20; Instruments S.A., Inc., Metuchen,
NJ) and detected by a cooled broadband photomultiplier tube (Hama-
matsu Corp., Middlesex, NJ) in the photon counting mode. Lifetime data
were collected on a multichannel sealer (model TN- 1750; Tracor North-
ern, Middleton, WI) and transferred to a MINC-23 minicomputer
(Digital Equipment Corp., Marlboro, MA) for storage and analysis. The
excitation and the emission spectra were recorded directly on an X-Y
plotter via a digital/analog interface built in our laboratory. The emission
and the excitation spectra reported here are uncorrected. Analyses of the
decay curves were performed on the MINC-23 using a nonlinear least
squares fitting method.
The number of water molecules q in the first coordination sphere of
Eu3+ bound to protein was calculated as described by Horrocks and
Sudnick (12, 13) using the equation q = 1.05 ms (KH2O-KD20). These
authors have shown an uncertainty of ±0.5 in the estimation of the
number of H20 molecules by this procedure. The lifetimes were measured
in H20-D20 buffer mixtures with different mole fractions of H20. The
decay constant k = 1/T was plotted as a function of X, the mole fraction of
H20. The decay constant k in 100% D20 was estimated by extrapola-
tion.
The concentrations of free Eu3", Ca2+, and Mg2, were calculated using
algorithms of Goldstein using a MINC-23 minicomputer (24). The
association constant for Eu3+ to ATP was 6 x 1O6 M-' (25).
In all of the luminescence measurements, 20 MM Eu3+ and 2 mg
protein/ml SR were used. These concentrations were chosen to keep a 2:1
mol ratio of Eu3+ to enzyme. It is reported that 40% of the protein content
of cardiac SR is (Ca2+ + Mg2+)-ATPase (2, 20). Taking the molecular
weight of (Ca2` + Mg2+)-ATPase to be 100 KDa, the 2 mg protein/ml is
therefore approximately equivalent to a 10 MM enzyme concentration.
Ki was calculated, using the Dixon plot for competitive inhibition (26).
The reciprocal of Ca2+-dependent ATPase activity was plotted for various
concentrations of free Eu3+.
RESULTS
Eu3+ Inhibition of ATPase Activity and
Ca2+ Uptake
To demonstrate that Eu3+ can compete with Ca2+ at the
Ca2+-activator sites of cardiac SR ATPase, we have stud-
ied the effect of Eu3+ on Ca2+-dependent ATPase activity
and Ca2+-uptake. It was found that Eu3+ inhibits both
Ca2+-dependent ATPase and Ca2+-uptake in a parallel
manner as shown in Figs. 1 and 2. In the presence of 60 .uM
CaC12, the concentration of Eu3` required for 50% inhibi-
tion of both functions was 0.6 ,M. The inhibition of the
ATPase activity by Eu3+ in the presence of 30 and 60 ,uM
CaC12 concentrations is shown in Fig. 1. From this figure,
it is clear that the concentration of Eu3+ required for 50%
inhibition of ATPase varies with CaC12 concentration. In
the inset, the Dixon plot for competitive inhibition is
displayed (26). K, was calculated as described in the
Materials and Methods section. The Ki value obtained
using these data is 50 nM. Our studies on the inhibition of
the ATPase activity by Eu3+ are consistent with the
lanthanide inhibition of the skeletal muscle enzyme (9-
1 1). Inhibition of the Ca2+-uptake (Fig. 2), which has not
been reported previously, further supports the existence of
a competition between Eu3+ and Ca2+ for the Ca2+ sites.
Phosphoenzyme Formation in the Presence
of 20 uM Eu3+
We have also investigated the phosphoenzyme (EP) for-
mation in the presence of 20 ,uM Eu3+; the data are shown
in Fig. 3. These studies were performed in conjunction with
our spectroscopic measurements using 20 ,uM Eu3+. Fig. 3
shows the time course of EP formation in the presence of
20 ,uM Eu3+. For comparison, the data obtained in the
presence of 20 ,M CaC12 and 5 mM EGTA are also
shown. These results clearly show the formation of EP in
the presence of 20 ,uM Eu3+, although the EP formation is
slower when compared with that occurring with Ca2 .
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FIGURE 1 Ca2+-dependent ATPase activity of (Ca2" + Mg2+)-ATPase of cardiac SR for various concentrations of Eu3+. 200 ,g protein/ml
SR vesicles were suspended in 0.4 ml of a reaction mixture containing 10mM K-MOPS (pH 6.8), 100 mM KCl, 10mM MgCl2, 5 mM NaN3,
and (A) 30 AM CaCl2, and (B) 60 ,uM CaCl2. Eu3+ concentration was varied from 0 to 1 mM. The reaction was started by adding 5 mM Tris
(Y-32P)ATP and was quenched by adding 0.2 ml of 10% TCA at the required time. The free Eu3+ concentrations shown in the abscissa were
calculated as described in the Materials and Methods section. (Inset) reciprocal of ATPase activity (1/V) vs. free Eu3+ plot for (A) 30,uM
CaCl2 and (B) 60,gM CaCI2.
Fluorescence Emission
and Excitation Spectra
The fluorescence spectra of Eu3+ in the absence and
presence of the SR preparation were recorded using 390
nm ('FO - 5L6) excitation wavelengths and are shown in
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FIGURE 2 Ca2+-uptake by cardiac SR in the presence of various
concentrations of Eu3+. Membrane vesicles were suspended at a concen-
tration of 200 Mg protein/ml in 0.4 ml of a reaction mixture containing 10
mM K-MOPS (pH 6.8), 100 mM KCI, 10 mM MgCl2, 5 mM NaN3, 5
mM Tris-ATP, and 60 MM 43CaC12. Eu3+ concentration was varied from 0
to 1 mM. The reaction was started by adding 5 mM Tris-ATP and the
reaction mixture was filtered through 0.2-M membrane at the required
time. The membrane vesicles bound to the millipore filter were washed
with the reaction buffer. Free Eu3+ concentrations given in the abscissa
were calculated as described in Materials and Methods section.
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FIGURE 3 Time course of phosphoenzyme (EP) formation of
(Ca2" + Mg2")-ATPase of cardiac SR. EP formation was measured with
250 Mg/ml cardiac SR in 0.2 ml of a reaction mixture containing 10 mM
K-MOPS (pH 6.8), 100 mM KCI, 5 mM MgCl2, 5 mM NaN3, and (A)
20M,M CaC12, (B) 20MM EuC13, and (C) 5 mM EGTA. The reaction was
started by adding 50 MM Tris-(y-32P)ATP and was terminated at the
required time by adding 2 ml cold 10% TCA containing 0.2mM ATP and
0.1 mM KH2PO4. 0.2 ml of 0.63% BSA was used as carrier protein. After
incubation on ice, the samples were centrifuged and washed three times.
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FIGURE 4 Emission spectra of Eu3+ in cardiac SR. The medium
contained in 10 mM K-MOPS, 100 mM KC1, and 5 mM MgC12 (pH
6.8). Concentrations of SR and Eu3+ were 2 mg protein/ml and 20 ,4M,
respectively. ATP used was 50 t,M. The excitation wavelength was 394
nm (7Fo - 'LO). (a) Eu3+ without SR, (b) Eu3+ with SR, and (c) Eu3+
with SR in the presence of 50 ,uM ATP.
Fig. 4. The fluorescence spectrum of Eu3+ in K-MOPS
(pH 6.8) exhibited three main emission bands at 593 nm
(5Do - "FI), 618 nm (5Do "F2), and 690 nm ('Do-) F4),
and one weak band at 650 nm (5Do -, "F3). In the presence
of the enzyme source, a fivefold enhancement of total
fluorescence intensity was observed. In addition, the rela-
tive intensity of the 618 nm (5Do-7"F2) band changed
dramatically. This is most likely due to the change in the
ligand environment around the Eu3+ ion (13). This phe-
nomenon is due to a hypersensitive characteristic asso-
ciated with the /.J = 2 transition.
To study the binding sites of cardiac SR ATPase, we
chose the 7Fo-- 5Do transition of Eu3+ because it possesses
certain unique advantages. Both the ground state ("FO) and
the excited state (5DO) are nondegenerative (13) and
cannot be split by a ligand field. Thus, this transition must
generate a single unsplit line for a given Eu3+ site. The
excitation spectrum for the 7Fo-, 'Do transition of Eu3+
was scanned from 578 nm to 580.5 nm, by monitoring the
emission intensity for 5Dn- 7F2 transition of Eu3+ at 618
nm. The excitation spectra for the 7Fo-- 5Do transition of
Eu"3 with and without the SR preparation are given in Fig.
5. The excitation spectrum of Eu3+ in 10 mM K-MOPS
(pH 6.8) with SR exhibited a maximum peak at 579.3 nm,
whereas in the absence of SR the peak was at 578.8 nm.
The width at half height of the composite band of the
EU3+-SR complex is 0.7 nm as compared with 0.5 nm for
the EU3+ aqua ion. The excitation spectrum of the EU3+-SR
complex also showed an additional feature on the low
energy side that was absent in the case of the EU3+ aqua
ion.
Fluorescence Decay Times
The fluorescence decay curve of the EU3+-SR complex was
multi-exponential, which indicates the presence of more
578.0 579.0 580.0
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FIGURE 5 Excitation spectra for 'F6-5Do transitions of Eu3+ in cardiac
SR. The medium contained 10 mM K-MOPS, 100 mM KC1, and 5 mM
MgC12 (pH 6.8). SR concentration was 2 mg protein/ml, whereas Eu3+
was 20 ,M. The concentrations of ATP was 50 ,uM. Excitation spectra
were recorded from 578-580.5 nm for 7F0-o5Do transition by monitoring
the emission intensity for 5Do_7F2 transition at 618 nm. (a) Eu3+ without
SR, (b) Eu3+ with SR, and (c) Eu3+ with SR in the presence of 50 ,uM
ATP.
than one emitting species in the system. The decay curves
were analyzed by the method of least squares analysis.
Table I shows the parameters obtained for single, double,
and triple exponentials. We rejected a one component fit
on the basis of the x2 analysis. A three-component fit was
also not acceptable in view of the large uncertainty in the
lifetime data and low value of fractional intensity of the
third component. Therefore, the best fit could be obtained
for two exponentials. The two decay components obtained
were 302 ± 5 ,us and 847 + 15 ,us with the fractional
intensities of 0.62 and 0.38, respectively. The two decay
components observed represent two distinct Eu3+-binding
sites on the protein. In K-MOPS, Eu3+ showed a single
exponential with a lifetime of 114 + 5 ,us. We have also
measured the lifetimes of the Eu3+-SR complex using
579.0 and 579.6 nm excitation wavelengths, but no signifi-
cant difference in the lifetime values was observed. The
lifetime data given in Table II are the average of three
measurements for the excitation at 579.3 nm.
Effect of ATP and ATP Analogue
The effect of ATP on the fluorescence intensity and the
lifetimes of Eu3+ bound to SR was studied. In the presence
of ATP, we observed a decresae in the fluorescence inten-
sity with no change in the peak position, whereas the
lifetime values showed an increase. Fig. 6 shows the decay
curve of Eu3+ bound to SR in the presence of ATP. The
decay curve is a double exponential and the lifetimes are
502 + 16 ,us and 1193 + 48 gis. The decay times of both
components showed an increase in the presence of ATP.
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TABLE I
No. of . Amplitudes Fractional 2
exponentials (a,) intensity
Eu3+ in cardiac SR Single 477.19 + 6.5 1.0 1.0 42
Double -= 302 + 5 0.70 0.62 0.92
-2= 847 + 15 0.14 0.38
Triple rl = 278 + 12 0.62 0.54 0.86
-2= 704 + 132 0.21 0.43
13 - 1,683 + 1,892 0.006 0.03
Analysis of single, double, and triple exponential curves of the fluorescence decay of Eu3+ in cardiac SR. The medium contained 10 mM K-MOPS, 100
mM KCI, and 5 mM MgCl2 (pH 6.8). The concentration of SR was 2 mg protein/ml and the concentration of Eu3+ was 20 gM. The excitation
wavelength was 579.3 nm and emission was monitored at 618 nm. The closeness of the fit for single, double, and triple exponentials were analyzed using a
nonlinear least squares algorithm.
However, in the presence of the ATP analogues AMP-
PNP and AMP-PCP, no significant change in the fluores-
cence lifetime was observed.
Control experiments with ATP in the absence of SR
were performed. ATP is known to bind with Eu3+ (25).
The excitation maximum of the Eu-ATP complex was at
579.0 nm, and the decay curve was a single exponential
with a lifetime of 165 ± 5 its.
TABLE II
Excitation . Nos. of
peak position H20
nm us
K-MOPS 578.8 114 9
K-MOPS + ATP 579.0 165 6
Cardiac SR 579.3 302 2.8
847 1.0
Cardiac SR + AMP-PCP 579.3 300 2.8
868 1.0
Cardiac SR + AMP-PNP 579.3 302 2.8
900 0.9
Cardiac SR + ATP 579.3 502 1.3
1,193 0.5
Effect of ATP and ATP analogues (AMP-PCP and AMP-PNP) on the
fluorescence parameters and the number of H20 molecules coordinated to
the Eu3+ ion. The medium contained 10 mM K-MOPS, 100 mM KCI,
and 5 mM MgCl2 (pH 6.8). SR and Eu3+ concentrations were 2 mg
protein/ml and 20 ,M, respectively. Concentration of ATP, AMP-PCP,
and AMP-PNP was 50 ,uM. The excitation wavelength used is given in
the second column, and the emission was monitored at 618 nm. Lifetime
data shown in the third column are the averages of three measurements.
The number of H2O molecules coordinated to Eu-SR were estimated as
described in the text using q = 1.05 (KH2O -KD2O). KH2O and KD2O
are the decay constants in H2O and 100% D2O, respectively. To determine
KD2O, the lifetime data were measured for various H2O-D2O buffer
mixtures and KD20 was obtained by linear extrapolation to 100% D20
(Fig. 7).
Number of Coordinated H20 Molecules
The number of water molecules coordinated to the Eu3+-
SR complex was calculated as described in the Materials
and Methods section. Fluorescence lifetimes of the Eu3+-
SR complex in H20-D20 buffer for various mole fractions
(x) of H20 were measured. The reciprocal of lifetime, i.e.,
the decay constant k = 1/, for various mole fractions of
H20 (X) was plotted as shown in Fig. 7. The value of the
decay constant in 100% D20 was determined by linear
extrapolation to 100% D20, the decay constant obtained by
this procedure was 0.78 ms-' for the short and 0.28 ms-1
0
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FIGURE 6 Luminescence decay curves of Eu3+ in cardiac SR. The
medium contained 10 mM K-MOPS, 100 mM KCI, and 5 mM MgCl2
(pH 6.8). SR concentration was 2 mg/ml whereas Eu3+ was 20 ,uM.
Measurements were performed using an excitation wavelength of 579.3
nm and an emission wavelength of 618 nm. (a) Eu3+ without SR, (b) Eu3+
with SR, and (c) Eu3+ with SR in the presence of 50,4M ATP.
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FIGURE 7 Luminescence decay constants k 1/T of the Eu3+-SR
complex for various mole fractions (x) of H20. The medium contained 10
mM K-MOPS, 100 mM KCI, and 5 mM MgCl2 (pH 6.8), and different
percentages of D20. SR concentration was 2 mg/ml and Eu3+ was 20 ,uM.
Measurements were performed using the 579.3 nm excitation and 618 nm
emission wavelengths. Short lived component: (A) without ATP, (B) with
ATP. Long lived component: (C) without ATP, (D) with ATP. Solid
lines, the linear least-squares fit.
for the long component of decay. The decay constant in
100% H20 was obtained directly from the lifetime mea-
surements. The number of H20 molecules estimated was
2.8 for the short component and 1.0 for the long component
of decay. Similar measurements were performed in the
presence of 50 AM each of AMP-PCP, AMP-PNP, and
ATP to estimate the number of H20 molecules coordinated
in their presence. In the presence of ATP, the decay
constants of Eu3+-SR complex for various mol fractions of
H20 are plotted in Fig. 7. The plots for AMP-PCP and
AMP-PNP are not shown. In the presence of ATP, the
number of water molecules coordinated to the Eu3+-SR
complex fell to 1.3 and 0.5 for the short and long decay
components. However, in the presence of AMP-PCP and
AMP-PNP, the nonhydrolyzable analogues of ATP, no
significant reduction of the number of H20 molecules
coordinated to the Eu3+-SR complex was observed. These
data are shown in Table II. The number of H20 molecules
given in Table II are estimated with an uncertainty of +0.5
(12).
DISCUSSION
The results of the present investigation suggest that Eu3+
binds to SR ATPase at two sites that are the two high
affinity Ca2+-binding sites. Krasnow (7) studied the bind-
ing of Gd3+ to cardiac SR and observed that Gd3+ binds to
the high affinity Ca2+-binding sites. He also observed a
decrease in the ATPase activity of SR with Gd3+ binding.
In the present studies, we observed an inhibition of the
Ca2'-dependent ATPase activity as well as the Ca -
uptake by Eu3+. We conclude that the binding of Eu3+ to
Ca2+-translocating sites is the reason for the inhibition of
the ATPase activity and the Ca2" uptake.
It was not possible to resolve the two binding sites from
the excitation spectrum of Eu3+ bound to SR. This may be
due to a charge similarity on the two Ca2" sites, because
the position of excitation maximum represents the total
charge on the Eu3+ ion (13). The results of the present
study showed an excitation peak at 579.3 nm for the
Eu3+-SR complex as compared with 578.8 nm for free
Eu3+. This red shift of bound Eu3+ is -15 cm-'. Sudnick
(13) has demonstrated that a red shift of 7.5 cm-' in peak
position corresponds to a neutralization of one unit charge.
In the present case the red shift of 15 cm-'in the excitation
peak for the Eu3+-SR complex as compared with the free
Eu3+ ion corresponds to a neutralization of two charges.
The double exponential nature of the decay curve of the
Eu3+-SR complex definitely suggests that Eu3+ binds to
two sites, which may reflect the high affinity Ca2"-sites of
cardiac SR. The association constant for lanthanide
attachment to Ca2+ binding ligands is usually much higher
than that for Ca2' because of their higher charge within
the same ionic radius. In the present case, the inhibition of
Ca2+-dependent ATPase by Eu3+ with a Ki of 50 nM
suggests that Eu3+ binds to these sites with high affinity.
The lower number of H20 molecules coordinated to the
Eu3`-SR complex, as compared with the free ion, indicates
that the metal ion sites are relatively unhydrated. The
different values of the number of H20 molecules for the
shorter (2.8) and the longer (1.0) decay components
indicate that the molecular environment of these sites is
different. Further reduction in the number of H20 mole-
cules to 1.3 and 0.5 in the presence of ATP for both decay
components strongly suggests that a change in the molecu-
lar environment of the Ca2+ binding is associated with EP
formation and the movement of the metal ion to an
occluded site in the enzyme. We suggest that the reduction
of the number of H20 molecules coordinated to the
Eu3+-SR complex in the presence of ATP is not due to a
simple binding process because nonhydrolyzable analogues
of ATP, such as AMP-PCP or AMP-PNP, did not cause a
significant reduction of H20 molecules. In preparations
from skeletal muscle enzyme using NMR techniques,
Stefens and Grisham (8) have reported a significant
reduction of the number of H20 molecules coordinated to
Gd3+ by AMP-PNP. Presently, we do not know the reason
for this apparent discrepancy. However, experiments per-
formed in our laboratory on skeletal SR using Eu3+ showed
no reduction of H20 molecules in the presence of AMP-
PNP (1 1). The reduction in the number of H20 molecules
to 1.3 and 0.5 indicates that the ATPase polypeptide
provides Eu3+ with about eight ligands to replace the H20
molecules. Therefore, in the case of Ca2 , these ligands
could strip the H20 molecules down to zero since the aqua
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Ca2" ion possess eight instead of nine H20 molecules that
are associated with the Eu3+ ion. These studies are consis-
tent with the studies on the skeletal muscle enzyme, which
demonstrate that the two high affinity sites for Ca2' are
heterogeneous in nature and that, in the phosphorylated
state of the enzyme, these sites are occluded (8, 1 1).
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